Surgery Versus 5% Imiquimod for Nodular and Superficial Basal Cell Carcinoma: 5-Year Results of the SINS Randomized Controlled Trial Hywel C. Williams, Fiona Bath-Hextall, Mara Ozolins, Sarah J. Armstrong, Graham B. Colver, William Perkins, Paul S.J. Miller Journal of Investigative Dermatology Volume 137, Issue 3, Pages 614-619 (March 2017) DOI: 10.1016/j.jid.2016.10.019 Copyright © 2016 The Authors Terms and Conditions
Figure 1 Flow of participants in the SINS trial from randomization until year 5. CONSORT flow diagram for SINS 5-year data. Journal of Investigative Dermatology 2017 137, 614-619DOI: (10.1016/j.jid.2016.10.019) Copyright © 2016 The Authors Terms and Conditions